Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c5d2abf422906eaa2f44b0444f72bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f1241a635a1d54aa0db0432acfe51b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba566e3f94c23beb3b219b22a58364c |
publicationDate |
2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013202593-A1 |
titleOfInvention |
Adjuvanted vaccines for serogroup B meningococcus |
abstract |
An immunogenic composition comprises (i) an immunostimulatory oligonucleotide and a polycationic polymer, wherein the oligonucleotide and the polymer ideally associate with each other to form a complex, and (ii) a meningococcal serogroup B antigen. In most embodiments, the 5 composition does not include an aluminium salt and does not include an oil-in-water emulsion. |
priorityDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |